Healthcare and Tech Lead SP 500 to Modest Gains Communication Services Lags Morrisons to Close 100 Stores Amid Rising Cost Pressures from Government Policies Pakistan Moves to Privatize Three StateOwned Power Distributors in Reform Push EEOC May End Longstanding Employer Demographic Data Collection Under Trump Administration Eli Lilly Reports Positive Phase 3 Results for Obesity Treatment Retatrutide Showcasing Significant Weight Reduction Morgan Stanley Signals Potential Turnaround for Franklin Resources BEN Riley Exploration Permian Inc REPX Q1 2026 Earnings Deep EPS Miss Amid Strong Stock Rally Grindr Q4 2025 Earnings EPS Misses Estimates Amid Operational Adjustments Autolus Therapeutics Q1 2026 Earnings EPS Miss Reflects Ongoing RD Investment Solstice Advanced Materials Inc Q1 2026 Earnings EPS Miss Sent Shares Higher ACTG Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Revenue Unreported STRRP Q1 2026 Earnings Significant EPS Miss Triggers Stock Decline Alpha Tau Medical Warrant DRTSW Slides 12 as It Tests Key Support Levels Fennec Pharmaceuticals FENC Gains 17 as Shares Bounce Off Support Key Levels in Focus Leidos Holdings LDOS Rises 181 as Defense Technology Demand Supports Gains Whirlpool WHR Faces Selling Pressure as Shares Decline 216 to 434 MKDWELL Tech Inc MKDW Surges 465 as Shares Test Key Resistance Near 852 Beyond Inc Acquires Buy Buy Baby Brand Rights Eyes Reunification with Bed Bath Beyond XNCR Q1 2026 Earnings Earnings Miss by Wide Margin as Losses Deepen Crane Harbor Acquisition Corp Rights CHACR Surges 17 as Speculative Interest Drives Rights Higher Climb Bio Inc CLYM Edges Higher Navigating Support and Resistance Levels New Horizon Aircraft Ltd HOVR Surges 2661 Key Levels to Watch After Breakout Crane Harbor Acquisition Corp Rights CHACR Rally 1728 as Speculative Interest Drives Price Toward 1 Resistance CAMP4 Therapeutics Surges 45 as Biotech Sentiment Improves CAMP Tests Key Resistance AMTD Digital Inc HKD Posts 444 Gain Testing Resistance at 185 Oriental Culture Holding OCG Bounces From Support Eyes Resistance at 192 Aurinia Pharmaceuticals AUPH Pulls Back 142 as Stock Tests Key Support Near 1455